These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9777980)

  • 1. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
    Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
    Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
    Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
    Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to differentiate between T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease. Evidence for the value of MB1 and 4KB5 immunostaining.
    Schmidt U; Herbst J; Metz KA; Leder LD
    J Pathol; 1996 Jun; 179(2):138-44. PubMed ID: 8758204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow involvement in T-cell-rich B-cell lymphoma.
    Skinnider BF; Connors JM; Gascoyne RD
    Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
    Nguyen DT; Diamond LW; Hansmann ML; Fischer R
    Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
    Kraus MD; Haley J
    Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
    McBride JA; Rodriguez J; Luthra R; Ordóñez NG; Cabanillas F; Pugh WC
    Am J Surg Pathol; 1996 Feb; 20(2):193-201. PubMed ID: 8554109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell/histiocyte-rich B-cell lymphoma: histology, immunophenotype and differential diagnosis].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Luo XL
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):771-5. PubMed ID: 16545182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-rich B-cell lymphoma - diagnostic and therapeutic aspects.
    Axdorph U; Porwit-Macdonald A; Sjøberg J; Grimfors G; Bjørkholm M
    APMIS; 2002 May; 110(5):379-90. PubMed ID: 12076255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
    Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
    Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.
    Liu Y; Zhu X; Zhuang H; Lin H; Wu Q; Jiang G; Gu Y; Luo D; Luo X
    Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):227-30. PubMed ID: 12475440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A; Delarue R; Canioni D; Brousse N
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.